Wednesday, 13th March 36th TROG Cancer Research Annual Scientific Meeting 2024

This session is sponsored by:

9:00 - 9:05am Welcome to Country

9:05 - 9:10am Official Welcome - Councillor Dr Elizabeth Adamczyk, City of Newcastle, Lord Mayor’s Office

9:10 - 9:20am President's Report - Prof Trevor Leong

9:20 - 9:30am TROG Scientific Committee Report - A/Prof Sasha Senthi

                       Trial Portfolio Update

9:30 - 9:35am TROG Independent Data and Safety Committee - Prof Bryan Burmeister

• Vascular remodelling during radiotherapy at low and ultra-high dose rate (Flash)  - Stéphane SUPIOT

• Summary of TROG Breast portfolio - Farshad Foroudi and Tomas Kron
• Stereotactic Radiotherapy for Oligoprogressive ER-positive Breast Cancer (AVATAR): A Phase II Prospective Multicentre Trial - Emma Connolly
• PRELIMINARY RESULTS: TROG 08.06 STARS: A Randomised comparison of anastrozole commenced before and continuing during adjuvant radiotherapy for breast cancer versus anastrozole and subsequent anti-oestrogen therapy delayed until after radiotherapy. (Cat A, Open) - Peter Graham
• RESULTS TROG 12.02 PET LABRADOR: PET scans for locally advanced breast cancer and diagnostic MRI to determine the extent of operation and radiotherapy (Cat A, Open) - Verity Ahern
• Local HERO: A Phase II study of local therapy only ( stereotactic radiosurgery and/ or surgery) for treatment of up to 5 brain metastases from HER2+ breast cancer. TROG 16.02 - Claire Phillips
• The intersections between systemic and local therapy for breast cancer: current status and future opportunities - Nicholas Zdenkowski
• Whole breast knowledge-based planning predictions and transferability: a transcontinental consortia experience - Peter Griffin

Session sponsored by:

• Opportunities for extending cancer clinical trials to NZ rural and regional locations - Michael Jameson
• Enablers for the conduct of cancer clinical trials in rural and regional locations - Gerry Adams
• Learnings from the RTN-Vic and ReViTALISE initiatives: Enabling clinical trial participation across boundaries - Craig Underhill
• Investigating Oncologists’ attitudes towards the transition of patients to primary care for treatment follow-up - Georgia Halkett

Panel Discussion with:

A/Prof Michael Jameson, University of Auckland;

Dr Gerry Adams, Royal Australian and New Zealand College of Radiologists;

Dr Craig Underhill, Albury Wodonga Health/North East Health;

A/Prof Georgia Halkett, Curtin University

• Central Nervous System (CNS) Working Party update - Mark Pinkham
• The prospective, multi-centre trial evaluating FET-PET in Glioblastoma (FIG) study, TROG 18:06 - study update and current learnings - Eng-Siew Koh
• TD 23.02 Pre-operative radiosurgery for brain metastases (Cat A, In Development) - Neda Haghighi
• TD 23.02; Discussant  - Frank Saran
• Pre-operative SRS for brain metastases; DEGRO perspective - Susanne Rogers
• What are the next rad onc trials in brain metastases  - Yu Yang Soon

4.40pm Panel Discussion with:

A/Prof James Lynam, Calvary Mater;

Prof Frank Saran, Australian Bragg Centre; 

Dr Yu Yang Soon, National University Cancer Institute, Singapore;

Catherine Johnson, John Hunter Hospital;

A/Prof Haryana Dhillon, University of Sydney